211 related articles for article (PubMed ID: 22872288)
1. RNAi-mediated knockdown of pituitary tumor- transforming gene-1 (PTTG1) suppresses the proliferation and invasive potential of PC3 human prostate cancer cells.
Huang SQ; Liao QJ; Wang XW; Xin DQ; Chen SX; Wu QJ; Ye G
Braz J Med Biol Res; 2012 Nov; 45(11):995-1001. PubMed ID: 22872288
[TBL] [Abstract][Full Text] [Related]
2. [Downregulation of PTTG1 expression inhibits the proliferation and invasiveness and promotes the apoptosis of human prostate cancer LNCaP-AI cells].
Cao XL; Wei YY; Song XM; Lu KQ; Yu WC; Chen YQ; Liu YL; Gao JP
Zhonghua Nan Ke Xue; 2017 Jul; 23(7):589-597. PubMed ID: 29723450
[TBL] [Abstract][Full Text] [Related]
3. PTTG1 inhibits SMAD3 in prostate cancer cells to promote their proliferation.
Huang S; Liao Q; Li L; Xin D
Tumour Biol; 2014 Jul; 35(7):6265-70. PubMed ID: 24627133
[TBL] [Abstract][Full Text] [Related]
4. Knockdown of PTTG1 inhibits the growth and invasion of lung adenocarcinoma cells through regulation of TGFB1/SMAD3 signaling.
Li WH; Chang L; Xia YX; Wang L; Liu YY; Wang YH; Jiang Z; Xiao J; Wang ZR
Int J Immunopathol Pharmacol; 2015 Mar; 28(1):45-52. PubMed ID: 25816405
[TBL] [Abstract][Full Text] [Related]
5. Interleukin-6/signal transducer and activator of transcription 3 promotes prostate cancer resistance to androgen deprivation therapy via regulating pituitary tumor transforming gene 1 expression.
Huang S; Liu Q; Liao Q; Wu Q; Sun B; Yang Z; Hu X; Tan M; Li L
Cancer Sci; 2018 Mar; 109(3):678-687. PubMed ID: 29288516
[TBL] [Abstract][Full Text] [Related]
6. PTTG1, A novel androgen responsive gene is required for androgen-induced prostate cancer cell growth and invasion.
Zhang Z; Jin B; Jin Y; Huang S; Niu X; Mao Z; Xin D
Exp Cell Res; 2017 Jan; 350(1):1-8. PubMed ID: 27756608
[TBL] [Abstract][Full Text] [Related]
7. The clinical value and biological function of PTTG1 in colorectal cancer.
Ren Q; Jin B
Biomed Pharmacother; 2017 May; 89():108-115. PubMed ID: 28219049
[TBL] [Abstract][Full Text] [Related]
8. PTTG1 regulated by miR-146a-3p promotes bladder cancer migration, invasion, metastasis and growth.
Xiang W; Wu X; Huang C; Wang M; Zhao X; Luo G; Li Y; Jiang G; Xiao X; Zeng F
Oncotarget; 2017 Jan; 8(1):664-678. PubMed ID: 27893422
[TBL] [Abstract][Full Text] [Related]
9. Knockdown of lipocalin-2 suppresses the growth and invasion of prostate cancer cells.
Tung MC; Hsieh SC; Yang SF; Cheng CW; Tsai RT; Wang SC; Huang MH; Hsieh YH
Prostate; 2013 Sep; 73(12):1281-90. PubMed ID: 23775308
[TBL] [Abstract][Full Text] [Related]
10. Pituitary tumor transforming gene 1 promotes proliferation and malignant phenotype in osteosarcoma via NF-κB signaling.
Hu X; Yang F; Mei H
J Orthop Sci; 2024 Jan; 29(1):306-314. PubMed ID: 36414514
[TBL] [Abstract][Full Text] [Related]
11. [Regulation of expression of pituitary tumor transforming gene 1 (PTTG1) by androgen in prostate cancer].
Xin DQ; Zhu XH; Lai YQ; You R; Na YQ; Guo YL; Mao ZB
Beijing Da Xue Xue Bao Yi Xue Ban; 2005 Dec; 37(6):638-40. PubMed ID: 16378119
[TBL] [Abstract][Full Text] [Related]
12. The PTTG1-targeting miRNAs miR-329, miR-300, miR-381, and miR-655 inhibit pituitary tumor cell tumorigenesis and are involved in a p53/PTTG1 regulation feedback loop.
Liang HQ; Wang RJ; Diao CF; Li JW; Su JL; Zhang S
Oncotarget; 2015 Oct; 6(30):29413-27. PubMed ID: 26320179
[TBL] [Abstract][Full Text] [Related]
13. Prostate cancer cell response to paclitaxel is affected by abnormally expressed securin PTTG1.
Castilla C; Flores ML; Medina R; Pérez-Valderrama B; Romero F; Tortolero M; Japón MA; Sáez C
Mol Cancer Ther; 2014 Oct; 13(10):2372-83. PubMed ID: 25122070
[TBL] [Abstract][Full Text] [Related]
14. TERF1 downregulation promotes the migration and invasion of the PC3 prostate cancer cell line as a target of miR‑155.
Chen W; He LN; Liang Y; Zeng X; Wu CP; Su MQ; Cheng Y; Liu JH
Mol Med Rep; 2020 Dec; 22(6):5209-5218. PubMed ID: 33174061
[TBL] [Abstract][Full Text] [Related]
15. PTTG1 knockdown enhances radiation-induced antitumour immunity in lung adenocarcinoma.
Chen Z; Cao K; Hou Y; Lu F; Li L; Wang L; Xia Y; Zhang L; Chen H; Li R; Chang L; Li W
Life Sci; 2021 Jul; 277():119594. PubMed ID: 33984357
[TBL] [Abstract][Full Text] [Related]
16. PTTG1 promotes migration and invasion of human non-small cell lung cancer cells and is modulated by miR-186.
Li H; Yin C; Zhang B; Sun Y; Shi L; Liu N; Liang S; Lu S; Liu Y; Zhang J; Li F; Li W; Liu F; Sun L; Qi Y
Carcinogenesis; 2013 Sep; 34(9):2145-55. PubMed ID: 23671127
[TBL] [Abstract][Full Text] [Related]
17. Response of Myeloid Leukemia Cells to Luteolin is Modulated by Differentially Expressed Pituitary Tumor-Transforming Gene 1 (PTTG1) Oncoprotein.
Chen PY; Tien HJ; Chen SF; Horng CT; Tang HL; Jung HL; Wu MJ; Yen JH
Int J Mol Sci; 2018 Apr; 19(4):. PubMed ID: 29649138
[TBL] [Abstract][Full Text] [Related]
18. Significance of pituitary tumor transforming gene 1 (PTTG1) in prostate cancer.
Zhu X; Mao Z; Na Y; Guo Y; Wang X; Xin D
Anticancer Res; 2006; 26(2A):1253-9. PubMed ID: 16619532
[TBL] [Abstract][Full Text] [Related]
19. PTTG1 expression is associated with hyperproliferative disease and poor prognosis in multiple myeloma.
Noll JE; Vandyke K; Hewett DR; Mrozik KM; Bala RJ; Williams SA; Kok CH; Zannettino AC
J Hematol Oncol; 2015 Oct; 8():106. PubMed ID: 26445238
[TBL] [Abstract][Full Text] [Related]
20. The long non-coding RNA PTTG3P promotes cell growth and metastasis via up-regulating PTTG1 and activating PI3K/AKT signaling in hepatocellular carcinoma.
Huang JL; Cao SW; Ou QS; Yang B; Zheng SH; Tang J; Chen J; Hu YW; Zheng L; Wang Q
Mol Cancer; 2018 May; 17(1):93. PubMed ID: 29803224
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]